Jodie Collins, a bowel cancer survivor, is on a mission to empower others facing the same battle. She's developing a groundbreaking prehabilitation program, but it's not just any program—it's one that promises to be a game-changer for patients' quality of life and treatment outcomes. But here's where it gets personal...
After her own advanced bowel cancer diagnosis at 44, Collins experienced the anxiety and powerlessness that often accompany long wait times for diagnosis and treatment. She recognized that while patients may feel helpless in the face of cancer, they can take control of their health through exercise and nutrition. This realization sparked her passion project.
With a master's degree in sport and exercise science and a background in community education, Collins is well-equipped to make a difference. She's determined to create a customizable prehab program, working closely with patients, their families, and healthcare services to address individual needs. This holistic approach aims to support patients physically, mentally, and emotionally, ensuring they feel stronger and recover better from surgery and treatment.
And this is where her story gets even more inspiring... Collins' personal connection to bowel cancer runs deep. Her father and uncle both battled colorectal cancer, with her uncle successfully treated in his 30s and her father passing away within eight months of his diagnosis in his 70s. This family history motivated her to seek medical advice when she developed symptoms, leading to her own diagnosis.
After a challenging journey, Collins is now cancer-free and ready to take on this research project. She's grateful for the opportunity to focus on her work, knowing the impact it could have on others. The Cancer Society's National Research Grants Programme has awarded over $50 million in research funding over the past decade, and Collins is one of the recipients, receiving a scholarship for her PhD at Auckland University.
The Cancer Society's Director of Research and Innovation, Christelle Jolly, emphasizes the importance of supporting researchers like Collins. The organization's funding has propelled careers and advanced research in various fields, fostering momentum for progress. This round of grants includes postdoctoral fellowships, project grants, and scholarships, totaling over $1 million.
Among the recipients are Dr. Judy Ann Cocadiz, who will develop a device to detect cancer through DNA analysis, and Dr. Yue Wang, who will explore growth hormone inhibition to enhance melanoma treatments. Associate Professor Stephen Jamieson will investigate new treatments for NRAS-gene-related melanomas, while Dr. Andrea Teng will focus on Helicobacter pylori infection treatment efficiency.
A controversial question arises: Is personalized prehabilitation the future of cancer care? How can we ensure that patients have access to these potentially life-changing programs? Share your thoughts below!
